Komori
Changes in Officers4350MEDICAL SYSTEM NETWORK Co.,Ltd.Retail

Notice Regarding Changes in Directors and Changes in Representative Directors at a Consolidated Subsidiary

At the Company, the outside director will change from Isshiki Kozo (一色浩三) to Maruyama Yukinobu (丸山幸信). At the consolidated subsidiary ファーマシフト, the representative director and president will change from Tago Kentaro (多湖健太郎) to Kawano Shogo (川野尚吾), while Tago Kentaro (多湖健太郎) will change from representative director and president to director and chairman.

Worth reading
53Recurring
Scored from 4 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Who is moving to which position

Resolved 28 May 2026

Incoming appointee

2 items
Scheduled Appointment DateScheduled for 23 June 2026. The change in the Company's directors is scheduled to be formally approved at the 28th Annual General Meeting of Shareholders, scheduled for 23 June 2026.
Maruyama Yukinobu (丸山幸信)
Previous positionNot disclosed
New positionOutside directors
Kawano Shogo (川野尚吾)
Previous positionExecutive vice president and director (ファーマシフト)
New positionRepresentative director and president (ファーマシフト)
Number of shares held0 shares (record date Not disclosed)
Because the names and counts do not correspond, they are shown as reported without linking the counts to individual names.

Departing officer

2 items
Date of departureScheduled for 23 June 2026
Isshiki Kozo (一色浩三)Stepping down
Former PositionOutside directors
New positionNot disclosed
Tago Kentaro (多湖健太郎)Next role stated
Former PositionRepresentative director and president (ファーマシフト)
New positionDirector and chairman (ファーマシフト)

“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.

Whether the incumbent will remain in office (whether they will retain their position)

Tago Kentaro (多湖健太郎) will remain in office as director and chairman. No information is provided on whether Isshiki Kozo (一色浩三) will remain in office.

Filing as an independent officerMaruyama Yukinobu (丸山幸信) is scheduled to be reported to the Tokyo Stock Exchange as an independent officer.
Shareholders’ meeting approvalRequired. The proposal is presumed to concern the election of directors, although this is not explicitly stated in the document. The Company's 28th Annual General Meeting of Shareholders is scheduled for 23 June 2026.
Independent officers are outside officers registered with the exchange as having no conflict of interest with general shareholders.
Who is moving to which position
ItemDetails
Resolution date28 May 2026
Scheduled Appointment DateScheduled for 23 June 2026. The change in the Company's directors is scheduled to be formally approved at the 28th Annual General Meeting of Shareholders, scheduled for 23 June 2026.
Date of departureScheduled for 23 June 2026
Name of appointeeMaruyama Yukinobu (丸山幸信), Kawano Shogo (川野尚吾)
Appointee's new positionOutside directors, Representative director and president (ファーマシフト)
Appointee's previous positionNot disclosed, Executive vice president and director (ファーマシフト)
Number of shares held by the appointee0 shares (record date Not disclosed)
Name of departing officerIsshiki Kozo (一色浩三), Tago Kentaro (多湖健太郎)
Former position of departing officerOutside directors, Representative director and president (ファーマシフト)
New position of departing officerNot disclosed, Director and chairman (ファーマシフト)
Whether the incumbent will remain in officeTago Kentaro (多湖健太郎) will remain in office as director and chairman. No information is provided on whether Isshiki Kozo (一色浩三) will remain in office.
Filing as an independent officerMaruyama Yukinobu (丸山幸信) is scheduled to be reported to the Tokyo Stock Exchange as an independent officer.
Subject to Approval by the General Meeting of ShareholdersRequired. The proposal is presumed to concern the election of directors, although this is not explicitly stated in the document. The Company's 28th Annual General Meeting of Shareholders is scheduled for 23 June 2026.
Items this document does not state (8)
Appointee's date of birthYear the appointee joined the CompanyReason for departureReason for changeReasons for appointmentNumber of directors after the changeDetails of organizational changesChange in Corporate Governance Structure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

No reason for the changes is provided.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Changes in Directors and Changes in Representative Directors at a Consolidated Subsidiary | MEDICAL SYSTEM NETWORK Co.,Ltd. (4350) timely disclosure | Komori